The head of Claude Code hasn’t ‘written a line of code by hand’ in 8 months

Boris Cherny was asked at Brainstorm Tech if he was concerned about the rapid progress of AI: "Yes." ...
pharmaphorum

Change at the top of Recursion as co-founder leaves CEO role

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
The Hacker News

Six Proto6 Vulnerabilities in protobuf.js Expose Node.js Apps to RCE and DoS

Six Proto6 flaws in protobuf.js enable RCE and DoS attacks; patched in versions 7.5.6 and 8.0.2 to protect Node.js services.
InfoQ

Next.js 16.2: 400% Faster Dev Startup, Faster Rendering, and Deeper Tooling for AI Agents

Vercel has released Next.js 16.2, featuring performance enhancements that make development startup 400% faster and rendering ...
Morningstar

Recursion Pharmaceuticals Inc Class A RXRX

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

States press ahead with AI regulation despite Trump's push for federal control

States across the country are moving ahead with artificial intelligence regulations despite President Donald Trump's efforts ...
Hosted on MSN

Recursion outlines $800M cash runway through 2027 as leadership transition and partnership milestones drive next phase

Christopher Gibson, Co-Founder and CEO, announced, "beginning January 1, the amazing Najat Khan is going to take over the role of CEO, President and Director of Recursion." Gibson will transition to ...